Accenture holder plans Rule 144 sale of 3,588 shares

Accenture has a shareholder filing a Rule 144 notice to sell 3,588 Class A ordinary shares through UBS Financial Services on the NYSE.

Accepted by SEC EDGAR 01/26/2026 - 04:06 PM EST Learn about SEC filing dates

Rhea-AI Filing Summary

Accenture has a shareholder filing a Rule 144 notice to sell 3,588 Class A ordinary shares through UBS Financial Services on the NYSE. The planned sale has an aggregate market value of $1,016,301.00 with an approximate sale date of January 26, 2026. The shares were acquired from the issuer as stock awards on January 1, 2026 and January 5, 2026, in amounts of 3,224 and 364 shares, respectively. Class A ordinary shares outstanding were 660,432,542, providing context for the size of this planned sale.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the latest Form 144 filing for ACN show?

The Form 144 shows that a shareholder of Accenture (ACN) plans to sell 3,588 Class A ordinary shares under Rule 144 through a broker.

How many Accenture (ACN) shares are planned to be sold and what is their value?

The filing lists a planned sale of 3,588 Class A ordinary shares of Accenture with an aggregate market value of $1,016,301.00.

When and where are the Accenture (ACN) shares expected to be sold?

The approximate sale date is January 26, 2026, and the shares are expected to be sold on the NYSE through UBS Financial Services, Inc.

How were the Accenture shares in this Form 144 acquired?

The 3,588 Accenture Class A ordinary shares were acquired as stock awards from the issuer on January 1, 2026 (3,224 shares) and January 5, 2026 (364 shares).

How does the planned sale compare with Accenture shares outstanding?

The filing states that 660,432,542 Class A ordinary shares were outstanding, so the planned sale of 3,588 shares is very small compared with the total.

What is the role of UBS Financial Services in this Accenture Form 144?

UBS Financial Services, Inc., located in Weehawken, NJ, is listed as the broker handling the planned sale of 3,588 Accenture Class A ordinary shares on the NYSE.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001455134
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Accenture plc
SEC File Number	001-34448
Address of Issuer	1 GRAND CANAL SQUARE GRAND CANAL HARBOUR DUBLIN IRELAND D2
Phone	353-1-646-2000
Name of Person for Whose Account the Securities are To Be Sold	Burgum Melissa A
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Class A Ordinary	UBS Financial Services, Inc. 1000 Harbor Blvd 3rd Floor Weehawken NJ 07086	3588	1016301.00	660432542	01/26/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Class A Ordinary	01/01/2026	Stock Award	Issuer			3224	01/01/2026	N/A
Class A Ordinary	01/05/2026	Stock Award	Issuer			364	01/05/2026	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks
Date of Notice	01/26/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	10/28/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ UBS Financial Services Inc, as attorney-in-fact for Melissa Burgum
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)